Narayana Hrudayalaya Share Price update: NH gains today
NiveshIQ
NSE: NH · Healthcare
Narayana Hrudayalaya Ltd.
₹1,869.20▼ ₹40.50 (-2.12%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on NH. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Narayana Hrudayalaya Ltd.
Narayana Hrudayalaya Limited is a leading Indian healthcare services provider with a diversified portfolio of medical and healthcare services. The company operates through two segments: Medical and Healthcare Related Services, and Others. Its key revenue drivers include oncology, cardiology, and neurology services, which accounted for approximately 25% of its ₹7896 crore revenue in the latest fiscal year. Recently, the company has been in the news for its plans to take on ₹1,500 crore of debt and pay a dividend of ₹4.50 per share. Narayana Hrudayalaya has a strong competitive position in the Indian healthcare market, with a network of over 30 hospitals and clinics across the country. The company has a growth outlook driven by increasing demand for healthcare services in India and its expan
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹4,988 Cr +112.30% | ₹5,483 Cr +9.90% | ₹7,896 Cr +44.00% |
| EBITDA Margin | 23.04% | 23.27% | 21.74% |
| Net Profit | ₹790.00 Cr +141.60% | ₹791.00 Cr +0.10% | ₹866.99 Cr +9.60% |
| EPS | ₹38.62 | ₹38.66 | ₹39.89 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Narayana Hrudayalaya Share Price Jumps 3% As Kotak Securities Upgrades To 'Buy': Check Target Price
Narayana Hrudayalaya Share Price update: NH gains today
🔒
+ 3 more stories about Narayana Hrudayalaya Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹2, 684 Cr, PAT ₹207 Cr, EPS ₹10.20, EBITDA margin 18.8%. Growth context: revenue QoQ +3.5%, PAT QoQ -9.9%. Street verdict: miss, revenue surprise +11.6%, PAT surprise -20.3%.
Key drivers for the next 2-4 quarters will be test volumes, test mix, B2B/reference-lab traction, pricing discipline, an...
The company's FY26 results were marked by revenue of ₹7, 896 Cr, PAT of ₹867 Cr, EBITDA margin of 21.7%, and EPS of ₹39....
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for NH
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track NH alongside your other holdings
Unlock full NH research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Narayana Hrudayalaya Ltd.?
NiveshIQ detects active intelligence signals for Narayana Hrudayalaya Ltd. (NH) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Narayana Hrudayalaya Ltd.?
Narayana Hrudayalaya Ltd. operates in the Healthcare sector with a market capitalisation of ₹3,928,356.9L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.